4.7
慢性気管支炎は慢性閉塞性肺疾患(COPD)の主要な表現型であり、気道中心性の炎症と粘液の過剰生成を特徴とします。これは有害な粒子やガス、特にタバコの煙に長期間曝露されることから発症し、持続的な炎症反応を引き起こします。
炎症は最初、大気管支に影響を及ぼし、その後小さな気道に影響を及…
慢性気管支炎はCOPDの主要な表現型であり、タバコの煙などの空気中の刺激物に長時間曝露されることで発生します。
これらの刺激物は、大きな気管支から始まり、小さな気道にまで広がる持続的な炎症を引き起こします。
好中球、マクロファージ、リンパ球が気管支壁に浸潤し、上皮損傷を引き起こします。
炎症はまた扁平上皮化生を引き起こし、繊毛上皮を扁平上皮に置き換えて粘毛のクリアランスを妨げます。
一方、ゴブレット細胞や粘膜下腺は肥大と形成され、気道を詰まらせ感染を促進する粘液を分泌します。
持続的な炎症や粘液詰まりは気道の再構築を引き起こし、平滑筋肥大や線維症を引き起こし、特に呼気時に気道が狭くなります。
気道閉塞は換気と灌流の不一致を引き起こし、低酸素血症を引き起こします。進行的な空気の閉じ込めは過膨張を引き起こし、横隔膜を平らにし、換気効率を低下させ、呼吸の仕事量を増加させます。
View the full transcript and gain access to JoVE Core videos
Q1: What causes chronic bronchitis to develop?
Chronic bronchitis develops from prolonged exposure to airborne irritants, most commonly cigarette smoke. These irritants trigger persistent inflammation that begins in the larger bronchi and extends into smaller airways. Neutrophils, macrophages, and lymphocytes infiltrate the bronchial walls, causing epithelial injury and initiating a cascade of structural and functional changes.
Q2: How does squamous metaplasia affect the airways in chronic bronchitis?
Squamous metaplasia replaces the ciliated epithelium with non-ciliated squamous cells, impairing mucociliary clearance. This loss of ciliated cells reduces the airway's ability to trap and remove mucus and pathogens, increasing infection risk and allowing mucus to accumulate and damage airways progressively.
Q3: Why do goblet cells and submucosal glands enlarge in chronic bronchitis?
Persistent inflammation triggers hyperplasia and hypertrophy of goblet cells and submucosal glands. These enlarged structures produce excessive, thick mucus that clogs airways and promotes bacterial colonization. The increased Reid index reflects glands occupying over half the bronchial wall thickness, contributing to airflow obstruction.
Q4: What is the relationship between airway remodeling and breathing difficulty?
Airway remodeling includes smooth muscle hypertrophy, fibrosis, and inflammatory thickening that narrow airways, especially during expiration. Combined with mucus plugging, this obstruction causes air trapping and hyperinflation, which flattens the diaphragm, reduces tidal volume, and significantly increases the work of breathing.
Q5: How does chronic bronchitis impair gas exchange?
Airway obstruction and mucus plugging create a ventilation-perfusion mismatch where perfusion exceeds ventilation. This mismatch leads to hypoxemia and, in advanced cases, hypercapnia due to poor carbon dioxide clearance. Progressive airway damage reduces the lungs' ability to oxygenate blood and eliminate carbon dioxide effectively.
Q6: What are the main clinical symptoms of chronic bronchitis?
Chronic bronchitis presents with chronic productive cough, dyspnea, and frequent infections. These symptoms result from persistent airway inflammation, excessive mucus production, and impaired clearance mechanisms. Although lung parenchyma is relatively preserved compared to emphysema, progressive airway damage leads to declining lung function and worsening symptoms.
Q7: How does chronic bronchitis differ from emphysema in COPD?
Chronic bronchitis is characterized by airway-centered inflammation and mucus overproduction with relatively preserved lung parenchyma. In contrast, emphysema involves parenchymal destruction. Understanding both phenotypes is essential for recognizing that chronic obstructive pulmonary disease emphysema and chronic bronchitis represent distinct pathological processes within COPD.